ArticleFrontiers in immunology2025

Telitacicept as an alternative to non-steroidal immunosuppressive therapies in the treatment of myasthenia gravis: a study on clinical efficacy and steroid-sparing effect.

Zheyu Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.